Medacta Group Debt 2024

Medacta Group Aktienanalyse

What does Medacta Group do?

The Medacta Group SA is a leading global company in the development, manufacturing, and marketing of medical devices and implants for the orthopedic industry. The company was founded in 1999 by Swiss entrepreneur Alberto Siccardi and is headquartered in Switzerland. The Medacta Group SA has its origins in one person - Alberto Siccardi. As a former athlete and successful entrepreneur, he had a vision that he put into action. He founded the Medacta Group and began focusing on the development and manufacturing of innovative orthopedic devices and implants. The Medacta Group has an innovative business model because the company is able to handle everything from research and development to marketing and sales of its products. This means that Medacta combines all steps from idea to end product under one roof and has complete control over the entire process. The Medacta Group SA is divided into three business areas: orthopedics, spine, and sports medicine. In the orthopedic field, the company manufactures hip and knee joint implants, as well as shoulder and elbow implants. Medacta also offers technologies that help extend the lifespan of artificial joints. In the spine field, the company provides instruments and implants for spine surgery. Medacta has a high level of expertise in this field and is known for innovative products that contribute to improving patient treatment. In the sports medicine field, the Medacta Group offers solutions for sports injuries. The company has developed a wide range of technologies and products that accelerate the healing process and support rehabilitation. Some of Medacta's most well-known products are the AMIS (Anterior Minimally Invasive Surgery) hip joint system and the GMK (General Medacta Knee) knee joint system. The AMIS system is a minimally invasive procedure for hip joint surgery that aims to shorten rehabilitation time and reduce the risk of complications. The GMK system is an innovative knee joint system that allows natural joint mechanics and approximates the natural knee pivot point. Medacta has also developed a range of software solutions that support surgeons in the planning and execution of operations. These solutions provide detailed visualizations and allow for precise planning of procedures. In conclusion, the Medacta Group SA is a global leader in the development and manufacturing of medical devices and implants for orthopedics, spine, and sports medicine. The company has an innovative business model that allows for complete control of the entire manufacturing process. Through the development of innovative products and technologies, the Medacta Group supports the treatment and rehabilitation of patients worldwide. Medacta Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Medacta Group's Debt Structure

Medacta Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Medacta Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Medacta Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Medacta Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Medacta Group stock

What is the debt of Medacta Group this year?

Medacta Group has a debt level of 181.19 EUR this year.

What was the debt of Medacta Group compared to the previous year?

The debt of Medacta Group has increased by 71.37% compared to the previous year increased.

What are the consequences of high debt for investors in Medacta Group?

High debt can pose a risk for investors of Medacta Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Medacta Group?

Low debt means that Medacta Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Medacta Group affect the company?

An increase in debt of Medacta Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Medacta Group affect the company?

A reduction in debt of Medacta Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Medacta Group?

Some factors that can influence the debt of Medacta Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Medacta Group so important for investors?

The debts of Medacta Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Medacta Group take to change the debt?

To change the debt, Medacta Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Medacta Group pay?

Over the past 12 months, Medacta Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medacta Group is expected to pay a dividend of 0.31 EUR.

What is the dividend yield of Medacta Group?

The current dividend yield of Medacta Group is .

When does Medacta Group pay dividends?

Medacta Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medacta Group?

Medacta Group paid dividends every year for the past 0 years.

What is the dividend of Medacta Group?

For the upcoming 12 months, dividends amounting to 0.31 EUR are expected. This corresponds to a dividend yield of 0.23 %.

In which sector is Medacta Group located?

Medacta Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medacta Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medacta Group from 5/14/2024 amounting to 0.275 EUR, you needed to have the stock in your portfolio before the ex-date on 5/10/2024.

When did Medacta Group pay the last dividend?

The last dividend was paid out on 5/14/2024.

What was the dividend of Medacta Group in the year 2023?

In the year 2023, Medacta Group distributed 0.268 EUR as dividends.

In which currency does Medacta Group pay out the dividend?

The dividends of Medacta Group are distributed in EUR.